Loading...

COGT COGENT BIOSCIENCES INC Earnings Reports 8-K Filing

CGNT

CGT

COGENT BIOSCIENCES INC

(COGT)

2025 8-K

Financial Results Update

Clinical Trial Results

Convertible Notes Offering

Equity Offerings

Positive Trial Results

Quarterly Earnings

New Office Lease

Financial Statements

Equity Offerings

Product Expansion

Debt-Equity Swaps

Financial Statements

Financial Results

Clinical Trial Update

Financial Results

Clinical Trial Updates

Financial Results Announcement

FDA Alignment Announcement

Annual Meeting and Amendmen...

Earnings Reports

Unregistered Sales of Equit...

Financial Results Announcement

Private Placement

Positive Clinical Trial Dat...

Earnings Reports

Earnings Reports

Underwriting Agreement

Annual Meeting Approval

Positive Phase 3 PEAK trial...

Earnings Reports

Earnings Reports

External Links:

On August 5, 2025, Cogent Biosciences, Inc. announced its financial results for the quarter ending June 30, 2025. The filing includes a press release with additional detailed information attached as Exhibit 99.1.

AI Assistant

COGENT BIOSCIENCES INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.